Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (16.667%)
Market Cap: £15.36m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

Share Options

1 Apr 2010 12:26

RNS Number : 6351J
Symphony Environmental Tech. PLC
01 April 2010
 



 

 

1st April 2010

 

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

 

Share Options

 

 

Symphony Environmental Technologies Plc ("Symphony", the "Company" or the "Group") announces that the Board, on the recommendation of the Remuneration Committee, granted on 31st March 2010 share options to the Executive Directors of the Company in recognition of the results they have achieved in 2009.

 

A total of 1,050,000 options over the Company's ordinary 1p shares have been granted and allocated as to Michael Laurier 350,000; Ian Bristow 280,000; Michael Stephen 210,000; and Michael Stephens 210,000.

 

The options are exercisable for ten years at 9.125p per ordinary share being the mid market price on 31 March 2010.

 

Contacts:

 

Symphony Environmental Technologies plc

Michael Laurier, CEO

Ian Bristow, FD

  Tel: 020 8207 5900

 

Allenby Capital Limited

Nick Naylor/James Reeve

 

Tel: 020 3328 5656

Threadneedle Communications

Graham Herring/Josh Royston

 

Tel: 020 7653 9850

 

Symbol London. SYM.L

 

American Depositary Receipts ("ADR")

Symphony ADRs trade in the US on the OTC (Over The Counter) market under the symbol SETPY. The ADR to 1p ordinary share ratio is 1:100 and the CUSIP is 87156K104. BNY Mellon acts as sponsored depositary for Symphony's ADR facility.

 

 

Further information on the Symphony Environmental Technologies Group of companies:

 

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC considers itself a world leader in Controlled-life plastic technology and products - a system that works by a process called oxo-biodegradation. The technology is branded d2w® and appears as a droplet logo on many thousands of tonnes of plastic packaging and other plastic products.

 

Symphony has a diverse and growing customer-base and has established itself successfully as an international business. Products made with d2w plastic technology can now be found in more than 90 countries around the world and in many different product applications. Symphony is a member of the Oxo-biodegradable Plastics Association (www.biodeg.org), the Society for the Chemical Industry (UK), and the American Standards Organisation (ASTM). Symphony is also a member of The US Save the Plastic Bag Coalition (http://www.savetheplasticbag.com/) and the British Brands Group. Symphony actively participates in the work of the British Standards Institute (BSI) and the European Standards Organisation (CEN).

 

Symphony also owns d2p which is an anti-microbial technology that is used in most type of plastic product applications to help protect those products against bacteria and fungi growth. Symphony is also developing innovative and cost-effective waste-to-value technology to convert plastics, tyres and other waste-streams into valuable products.

 

Further information on the Symphony Group can be found at www.d2w.net.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSIFFFFSSEEL
Date   Source Headline
19th Nov 20218:24 amRNSExpansion into India
12th Nov 20213:04 pmRNSSmall Cap Awards: ESG Company of the Year
25th Oct 20217:00 amRNSExclusive Distribution Agreement
5th Oct 20219:58 amRNSHolding(s) in Company
24th Sep 20217:00 amRNSEquity subscription and grant of warrants
16th Sep 20217:00 amRNSInterim results
3rd Sep 20217:00 amRNSHealth Canada approves d2p for bread packaging
2nd Aug 20217:30 amRNSNew agreements with Meditech
27th Jul 20213:00 pmRNSHolding(s) in Company
14th Jul 20217:00 amRNSNew expanded FDA approval for d2p food packaging
13th Jul 20217:00 amRNSTrading update
28th Jun 202111:56 amRNSResult of AGM
11th Jun 202110:04 amRNSHolding(s) in Company
9th Jun 20217:00 amRNSPDMR Dealing
3rd Jun 20217:00 amRNSPosting of accounts & notice of AGM
13th May 20217:00 amRNSEU legal challenge update
23rd Apr 20217:32 amRNSd2p anti-microbial technology to protect commuters
13th Apr 20212:40 pmRNSDirector Dealing
1st Apr 20213:23 pmRNSDirector Dealing
31st Mar 20217:00 amRNSPreliminary results
30th Mar 20217:00 amRNSCompletion of 5 year Oxomar study re. d2w
12th Mar 20217:00 amRNSEU legal challenge update
9th Feb 20217:00 amRNSTrading update
21st Dec 20207:00 amRNSEU legal action
30th Nov 20207:00 amRNSPositive Coronavirus Test Results of d2p products
16th Nov 20207:00 amRNSNew d2p product launch
9th Nov 20204:40 pmRNSSecond Price Monitoring Extn
9th Nov 20204:36 pmRNSPrice Monitoring Extension
30th Oct 20207:00 amRNSLaunch of d2p and d2w enhanced drinking straws
20th Oct 20207:00 amRNSCompletion of Eranova project financing
19th Oct 20207:00 amRNSLargest Bakery in Turkey Launches d2w Packaging
9th Oct 20207:00 amRNSExtension of Options
5th Oct 20205:52 pmRNSHolding(s) in Company
28th Sep 20207:00 amRNSUK Airport Group introduces d2w biodegradable bag
22nd Sep 20207:00 amRNSCotripal launches d2p and d2w shopping bags
16th Sep 20207:00 amRNSInvestor Meet Company presentation
15th Sep 20207:00 amRNSExercise of warrants
14th Sep 20204:40 pmRNSSecond Price Monitoring Extn
14th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20207:01 amRNSPositive Coronavirus test results
14th Sep 20207:00 amRNSInterim results
13th Aug 20204:41 pmRNSSecond Price Monitoring Extn
13th Aug 20204:35 pmRNSPrice Monitoring Extension
12th Aug 20204:40 pmRNSSecond Price Monitoring Extn
12th Aug 20204:36 pmRNSPrice Monitoring Extension
4th Aug 20204:09 pmRNSPDMR dealing
29th Jul 20207:00 amRNSExercise of Options/PDMR dealing
28th Jul 20207:00 amRNSExercise of Options
23rd Jul 20207:00 amRNSPositive Bovine Coronavirus Test Results
22nd Jul 20207:00 amRNSExtension of warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.